Ricka Nishimura News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Roughly 1 in 500 people have hypertrophic cardiomyopathy, across all nations. Research by Cleveland Clinic suggests that an estimated 600,000 to 1.5 million...

December 23, 2020 Guidelines for the management of valvular heart disease (VHD) have been refreshed by the American College of Cardiology and American Heart Association—the first full revision since 2014. Most salient among the changes is the inclusion of the pivotal low-risk TAVR trials that led to US Food and Drug Administration approval for that indication last fall. With Catherine M. Otto, MD (University of Washington, Seattle), and Rick A. Nishimura, MD (Mayo Clinic, Rochester, MN), as co-chairs, the multisociety-produced document was published online last week in both Circulation and...

 E-Mail DALLAS and WASHINGTON, Dec. 17, 2020 -- Options to treat heart valve disease are expanding, allowing patients to avoid surgery when possible, according to a new joint clinical practice guideline from the American College of Cardiology and the American Heart Association. The new "2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease" published today in the AHA's flagship journal Circulation and in the Journal of the American College of Cardiology. About half of all people ages 65 and older have some form of valvular heart disease. If left undiagnosed or u...